SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-24-000154
Filing Date
2024-01-29
Accepted
2024-01-29 17:13:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 8 TO SCHEDULE 13D sc13da807422rain_01292024.htm SC 13D/A 299880
  Complete submission text file 0000921895-24-000154.txt   301654
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Oncology Inc. (Subject) CIK: 0001724979 (see all company filings)

IRS No.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92501 | Film No.: 24574618
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)